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Influenza vaccine is the most effective method of preventing influenza and its complications, but coverage rates are
not satisfactory. Therefore, an effective intervention is required to increase vaccination coverage. In a recent study
published in IJHPR, Yamin et al. identified the need to target risk perception in the public, as a major intervention
tool. Risk perception and compliance with vaccination guidelines was found to be mostly influenced by physician
recommendations. These findings are in-line with similar findings in the literature, stressing the importance of
patient-physician interaction in the patients’ decision to comply with vaccination guidelines produced by the public
health authorities. They also underscore the need to involve primary physicians in both the decision making process
as well in the vaccination campaign.Commentary
Influenza is an infectious disease of great importance
due to several reasons, including substantial mortality,
morbidity, and economic losses. Every few decades, it
has struck with devastating pandemics. Moreover, Influ-
enza is linked to incidence and mortality from one of the
most prevalent non-infectious diseases - cardiovascular
disease [1].
As the influenza vaccine has been found to be the
most effective method of preventing influenza and its
complications, many researchers have studied the deter-
minants of one’s decision whether to get the vaccine or
not, while many others have explored implementation
programs (IP’s) aimed at increasing the low vaccination
coverage. In an attempt to examine the combined effects
of these two factors, Yamin et al. [2] conducted the study
reported in a recent issue of the IJHPR.
Yamin et al. had conducted a telephone survey at the
end of the influenza season aimed at a representative
sample of 917 subjects in Israel. Of these, 470 (51%) fully
cooperated. In addition, convenience samples of several
sub-populations of particular interest (soldiers, students,
health care workers, Israeli Arabs and ultra-orthodox
Jews) were asked to complete paper questionnaires.* Correspondence: Rami.grifat@lbhaifa.health.gov.il
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article, unless otherwise stated.In their analysis of the survey responses, the authors
divided the subjects into three vaccine acceptance cat-
egories: Acceptors (22%), Conditional-Acceptors (44%)
and Non-Acceptors (34%). Acceptance was found to
correlate positively with influenza risk perception and
negatively with vaccine risk perception. Another Israeli
research team involved in studying vaccine uptake [3,4],
has likewise divided the population into three groups:
compliers, trusting-reflective-non-compliers and non-
compliers. Interesting, that team’s grouping did not in-
corporate the respondents’ risk perception levels.
Yamin et al. emphasize the need to target risk percep-
tion in the public with intervention programs primarily
to increase coverage among conditional-acceptors, but
also potentially to convert non-acceptors to conditional-
acceptors, by raising risk perception of influenza and
lowering risk perception of the vaccine. Importantly, one
of the most commonly cited reasons for not getting the
vaccine is fear of side effects [5,6].
In line with the literature [7], the most effective inter-
vention program found by Yamin et al. was physician
recommendation. Some authors have called for develop-
ing and evaluating interventions that help physicians
and other health care professionals to more effectively
implement strong and routine recommendations for
vaccines. But we should not forget that the most import-
ant element that gives physicians major influence on
their patient’s decision about vaccination in general and
about influenza vaccination in particular, is trust. Trustntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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spect, empathy and transparency, as seen in the case of
nurses in Mother and Child Health Centers (MCHC’s)
who are trusted by all, and in particular by Arab mothers
in Israel. This leads to very high coverage of childhood
vaccinations (unpublished data). In our opinion, the inter-
vention program intended for physicians should start at
medical schools and extend through continuous medical
education for physicians. Such a program is expected to
benefit both physicians and patients in various fields,
including compliance with vaccination recommendations.
The second most effective intervention program was
found by Yamin et al. to be information pamphlets.
Firstly, the public demand for these is high, and sec-
ondly, they can be given at important and influential oc-
casions, such as the birth of a new baby. Despite the
lower efficacy of preparing and delivering pamphlets
relative to physician recommendation improvement, it is
much cheaper, faster and easier to implement.
Most importantly, health care professionals should not
limit themselves to the one intervention program that
was generally most effective, but should instead also
tailor special intervention programs, or a combination of
them, for special sub-populations. A recent event of
polio transmission in Israel was followed by a national
vaccination campaign with oral polio vaccine. The role
of the primary care physicians in advocating for vaccin-
ation as well as the activities in social media via the
internet, resulted in a high rate of compliance with pub-
lic health guidelines [8].
Lately, the scientific community is increasingly accept-
ing the idea that population effects of vaccines (i.e. herd
immunity) are as important, if not more important, than
individual effects. As mere examples, this was demon-
strated in the case of vaccinating against S. pneumonia,
rota virus and influenza. These population effects
were achieved by vaccinating the most infectious sub-
population, in case of influenza infants (above six
months old) and young children [9]. This leads to the
conclusion that in addition to intervention programs
intended to protect individuals, efforts should be made
to vaccinate the easily accessible populations of young
children in schools or infants in MCHC’s. Adding the
influenza vaccine to the routine vaccine schedule should
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